These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35078668)

  • 41. Advances in the treatment of diabetic retinopathy.
    Singh RP; Elman MJ; Singh SK; Fung AE; Stoilov I
    J Diabetes Complications; 2019 Dec; 33(12):107417. PubMed ID: 31669065
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Diabetic Retinopathy Barometer Study: Global perspectives on access to and experiences of diabetic retinopathy screening and treatment.
    Cavan D; Makaroff L; da Rocha Fernandes J; Sylvanowicz M; Ackland P; Conlon J; Chaney D; Malhi A; Barratt J
    Diabetes Res Clin Pract; 2017 Jul; 129():16-24. PubMed ID: 28499163
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of Diabetic Retinopathy in Indigenous and Non-Indigenous Australians: A Systematic Review and Meta-analysis.
    Chia MA; Taylor JR; Stuart KV; Khawaja AP; Foster PJ; Keane PA; Turner AW
    Ophthalmology; 2023 Jan; 130(1):56-67. PubMed ID: 35931223
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema.
    ; ; Aiello LP; Beck RW; Bressler NM; Browning DJ; Chalam KV; Davis M; Ferris FL; Glassman AR; Maturi RK; Stockdale CR; Topping TM
    Ophthalmology; 2011 Dec; 118(12):e5-14. PubMed ID: 22136692
    [TBL] [Abstract][Full Text] [Related]  

  • 45. VEGF-A gene polymorphisms and responses to intravitreal ranibizumab treatment in patients with diabetic macular edema.
    Tetikoğlu M; Yüksel Z; Aktas S; Sağdik HM; Özcura F
    Int Ophthalmol; 2018 Dec; 38(6):2381-2388. PubMed ID: 29030794
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diabetic macular edema: changing treatment paradigms.
    Arevalo JF
    Curr Opin Ophthalmol; 2014 Nov; 25(6):502-7. PubMed ID: 25211039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Emerging pharmacotherapies for diabetic macular edema.
    Javey G; Schwartz SG; Flynn HW
    Exp Diabetes Res; 2012; 2012():548732. PubMed ID: 22474425
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vascular Endothelial Growth Factor Inhibitors for Diabetic Retinopathy.
    Dhoot DS; Avery RL
    Curr Diab Rep; 2016 Dec; 16(12):122. PubMed ID: 27766582
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combined therapy for diabetic macular edema.
    Al Rashaed S; Arevalo JF
    Middle East Afr J Ophthalmol; 2013; 20(4):315-20. PubMed ID: 24339681
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-mydriatic ultrawide field scanning laser ophthalmoscopy compared with dilated fundal examination for assessment of diabetic retinopathy and diabetic macular oedema in Chinese individuals with diabetes mellitus.
    Szeto SKH; Wong R; Lok J; Tang F; Sun Z; Tso T; Lam TCH; Tham CC; Ng DS; Cheung CY
    Br J Ophthalmol; 2019 Sep; 103(9):1327-1331. PubMed ID: 30381391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of Ranibizumab in Eyes with Diabetic Macular Edema and Macular Nonperfusion in RIDE and RISE.
    Reddy RK; Pieramici DJ; Gune S; Ghanekar A; Lu N; Quezada-Ruiz C; Baumal CR
    Ophthalmology; 2018 Oct; 125(10):1568-1574. PubMed ID: 29752001
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The effect of intravitreally administered angiogenesis inhibitor on the concentration of angiotensin-converting enzyme in the blood serum and lacrimal fluid in patients with diabetic macular edema].
    Neroev VV; Chesnokova NB; Okhotsimskaya TD; Ryabina MV; Fadeeva VA; Pavlenko TА; Beznos OV
    Probl Endokrinol (Mosk); 2019 Jun; 65(2):72-78. PubMed ID: 31271708
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy.
    Ip MS; Domalpally A; Sun JK; Ehrlich JS
    Ophthalmology; 2015 Feb; 122(2):367-74. PubMed ID: 25439595
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial.
    Baker CW; Glassman AR; Beaulieu WT; Antoszyk AN; Browning DJ; Chalam KV; Grover S; Jampol LM; Jhaveri CD; Melia M; Stockdale CR; Martin DF; Sun JK;
    JAMA; 2019 May; 321(19):1880-1894. PubMed ID: 31037289
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Burden of diabetic macular oedema in patients receiving antivascular endothelial growth factor therapy in South Korea: a healthcare resource use and cost analysis.
    Jeon HL; Lee H; Yoon D; Lee Y; Kim JH; Jee D; Shin JY
    BMJ Open; 2020 Dec; 10(12):e042484. PubMed ID: 33376178
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New Insights in Resistant Diabetic Macular Edema.
    Kuroiwa DAK; Malerbi FK; Regatieri CVS
    Ophthalmologica; 2021; 244(6):485-494. PubMed ID: 34023834
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation between Diabetic Retinopathy Severity and Oxygen Metabolism in Patients with Diabetic Macular Edema during Treatment with Intravitreal Aflibercept.
    Blindbæk SL; Peto T; Grauslund J
    Ophthalmic Res; 2020; 63(2):106-113. PubMed ID: 31715608
    [TBL] [Abstract][Full Text] [Related]  

  • 58. En Face Doppler Optical Coherence Tomography Measurement of Total Retinal Blood Flow in Diabetic Retinopathy and Diabetic Macular Edema.
    Lee B; Novais EA; Waheed NK; Adhi M; de Carlo TE; Cole ED; Moult EM; Choi W; Lane M; Baumal CR; Duker JS; Fujimoto JG
    JAMA Ophthalmol; 2017 Mar; 135(3):244-251. PubMed ID: 28196198
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice.
    Heier JS; Bressler NM; Avery RL; Bakri SJ; Boyer DS; Brown DM; Dugel PU; Freund KB; Glassman AR; Kim JE; Martin DF; Pollack JS; Regillo CD; Rosenfeld PJ; Schachat AP; Wells JA;
    JAMA Ophthalmol; 2016 Jan; 134(1):95-9. PubMed ID: 26512939
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aflibercept for the treatment of diabetic macular edema.
    Harkins KA; Haschke M; Do DV
    Immunotherapy; 2016 May; 8(5):503-10. PubMed ID: 26907516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.